Intelicare Holdings Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Daniel Pilbrow

Algemeen directeur

AU$384.1k

Totale compensatie

Percentage CEO-salaris	72.9%
Dienstverband CEO	2.3yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	2.6yrs
Gemiddelde ambtstermijn bestuur	2.6yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Daniel Pilbrow's beloning veranderd ten opzichte van Intelicare Holdings's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$384k	AU$280k	-AU$2m
Mar 31 2024	n/a	n/a	-AU$2m
Dec 31 2023	n/a	n/a	-AU$1m
Sep 30 2023	n/a	n/a	-AU$2m
Jun 30 2023	AU$477k	AU$267k	-AU$3m

Compensatie versus markt: De totale vergoeding ($USD 249.97K ) Daniel } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 298.08K ).

Compensatie versus inkomsten: De vergoeding van Daniel is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Daniel Pilbrow

2.3yrs

Tenure

AU$384,105

Compensatie

Mr. Daniel Pilbrow has been Chief Executive Officer at Intelicare Holdings Limited since July 18, 2022. He is also a former Investment Director for Social Care with AMP Capital and was previously Chief Str...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Daniel Pilbrow	Chief Executive Officer	2.3yrs	AU$384.11k	geen gegevens
Gregory Leach	Founder & Non-Executive Director	no data	AU$49.66k	4.89% A$ 238.3k
Michael Tappenden	Chief Technology Officer	4.9yrs	AU$209.05k	geen gegevens
Pieter Klopper	Chief Financial Officer	1.4yrs	geen gegevens	geen gegevens
Claudia Dent	Marketing Manager	2.8yrs	geen gegevens	geen gegevens
Neil Hackett	Company Secretary	no data	AU$73.46k	geen gegevens

2.6yrs

Gemiddelde duur

Ervaren management: Het managementteam van ICR wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Gregory Leach	Founder & Non-Executive Director	no data	AU$49.66k	4.89% A$ 238.3k
Neale Fong	Non-Executive Chair	2.6yrs	AU$122.25k	geen gegevens
Anne McCormack	Member of Clinical Advisory Committee	2.6yrs	geen gegevens	geen gegevens
Timothy Chapman	Independent Non-Executive Director	less than a year	geen gegevens	0.27% A$ 13.4k

2.6yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van ICR wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.6 jaar), wat duidt op een nieuw bestuur.

Intelicare Holdings Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Intelicare Holdings Limited, Annual General Meeting, Nov 29, 2024

Intelicare Holdings Limited, Annual General Meeting, May 31, 2024

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Intelicare Holdings Limited, Annual General Meeting, Nov 29, 2024

Full year 2024 earnings released: AU$0.01 loss per share (vs AU$0.018 loss in FY 2023)

New major risk - Shareholder dilution

Intelicare Holdings Limited, Annual General Meeting, May 31, 2024

Less than half of directors are independent

New major risk - Financial position

Less than half of directors are independent

Less than half of directors are independent

Intelicare Holdings Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Intelicare Holdings Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Intelicare Holdings Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Less than half of directors are independent

Intelicare Holdings Limited, Annual General Meeting, Nov 28, 2023

Less than half of directors are independent

Full year 2023 earnings released: AU$0.018 loss per share (vs AU$0.038 loss in FY 2022)

New minor risk - Financial data availability

Less than half of directors are independent

Less than half of directors are independent

InteliCare Holdings Ltd Announces Step Down of Scott Taylor as Non-Executive Director, Effective 13 June 2023

Less than half of directors are independent

Less than half of directors are independent

First half 2023 earnings released: AU$0.018 loss per share (vs AU$0.02 loss in 1H 2022)

Intelicare Holdings Limited Announces an Expansion of Their Services to Include Personal Emergency Response

Intelicare Holdings Limited, Annual General Meeting, Nov 29, 2022

Intelicare Holdings Limited Announces Director Changes

Full year 2022 earnings released: AU$0.038 loss per share (vs AU$0.058 loss in FY 2021)

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Intelicare Holdings Limited Announces Major Board Appointments and New Strategic Direction

Intelicare Holdings Limited Announces Executive Changes

Less than half of directors are independent

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

InteliCare Holdings Ltd Announces Board and Committee Changes

Full year 2021 earnings released: AU$0.058 loss per share (vs AU$0.06 loss in FY 2020)

Intelicare Holdings Limited announced that it expects to receive AUD 2.573 million in funding

InteliCare Holdings Ltd Announces Appointment of Gary Elwell of Gap Corporate Services as Chief Financial Officer

New 90-day high: AU$0.30

First half 2021 earnings released: AU$0.016 loss per share (vs AU$0.026 loss in 1H 2020)

InteliCare Holdings Ltd Signs Five Year Strategic Supply Agreement with Optus Networks Pty Ltd

New 90-day low: AU$0.23

Full year earnings released - AU$0.06 loss per share

Intelicare Holdings Limited Launches B2C Strategy with New Online Sales Platform and Ecommerce Marketplace

New 90-day low: AU$0.27

New 90-day low - AU$0.30

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur